Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• D0151023,4-Dihydroxyphenylacetic AcidMeSH

  A deaminated metabolite of LEVODOPA.

• D0151043,4-MethylenedioxyamphetamineMeSH

  An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

• C5807833,4-bis(2,4-difluorophenyl)-maleimideMeSH

  structure in first source

• C5881433,4-bis(4-chlorophenyl)pyrrolidin-2-oneMeSH

  also has norepinephrine reuptake inhibitory activity; structure in first source

• C5871703,4-bis(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazoleMeSH

  structure in first source

• C5698023,4-bis(isoproylamino)cyclobut-3-ene-1,2-dioneMeSH

  structure in first source

• C5845503,4-bis(methanethiosulfonylmethyl)-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yloxyMeSH

  structure in first source

• C5604633,4-dehydrotheaspironeMeSH

  cytotoxic from Juniperus brevifolia leaves; structure in first source

• C5714203,4-di-O-galloyl-1-O-purpurogallin carbonyl quinic acidMeSH

  from the leaves of Castanopsis fissa; structure in first source

• C5681213,4-diamino-1,2,4-triazoleMeSH

  structure in first source

• C5863793,4-diaza-benzvaleneMeSH

  structure in first source

• C5841323,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diolMeSH

  structure in first source

• C5834763,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isopropoxymethyl)benzyl)benzene-1,2-diolMeSH

  originally from red alga Rhodomela confervoides; structure in first source

• C5815813,4-dichlorinated biphenylMeSH

  structure in first source

• C5613403,4-dichlorophenylureaMeSH

  structure in first source

• C5812123,4-difluoro-N-(2-(1-(3-fluorophenyl)-4-oxo-1,3,8-triazaspiro(4.5)decan-8-yl)ethyl)benzamideMeSH

  has antineoplastic activity; structure in first source

• C5869523,4-difluoroacetophenone-thiosemicarbazoneMeSH

  structure in first source

• C5811623,4-dihydro-12-hydroxy-2,2-dimethyl-2H,6H-pyrano(3,2-b)xanthen-6-oneMeSH

  inhibits the interaction between p53 and MDM2; structure in first source

• C5716573,4-dihydro-2-(4-chlorophenyl)-6-(4-methoxyphenyl)-4-oxo-pyrimidine-5-carbonitrileMeSH

  structure in first source

• C5860123,4-dihydro-2-(hydroxymethyl)-4-methyl-2H-pyrrol-2-olMeSH

  from fruit and bark of Callistemon viminalis; structure in first source

• C5716563,4-dihydro-2-phenyl-6-para-fluorophenyl-4-oxo-pyrimidine-5-carbonitrileMeSH

  structure in first source

• C5716503,4-dihydro-3-(2'-hydroxyethylene)-6-ethyl-2H-benzoxazineMeSH

  structure in first source

• C5716523,4-dihydro-3-(2'-hydroxyethylene)-6-methoxy-2H-benzoxazineMeSH

  structure in first source

• C5716493,4-dihydro-3-(2'-hydroxyethylene)-6-methyl-2H-benzoxazineMeSH

  structure in first source

• C5850713,4-dihydroxy-5-nitrobenzaldehydeMeSH

  structure in first source

• C5837453,4-dihydroxyphenethoxy-8-O-beta-D-(6-O-(4-O-beta-D-glucopyranosyl)-feruloyl)glucopyranosideMeSH

  from the whole plant of Aconitum tanguticum (Maxim.) Stapf; structure in first source

• C5599193,4-dihydroxyphenylacetaldehyde synthase, Aedes aegyptiMeSH

  catalyzes the conversion of L-DOPA to 3,4-dihydroxyphenylacetaldehyde

• C5864903,4-dihydroxypipecolic acidMeSH

  structure in first source

• C5758943,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamideMeSH

  has antineoplastic activity; structure in first source

• C5860423,4-dimethoxybenzonitrileMeSH

  structure in first source

• C5814163,4-dimethoxycinnamyl 9-O-beta-D-glucopyranosideMeSH

  from Juniperus rigida leaves and twigs; structure in first source

• C5798243,4-dimethoxyphenol 1-O-(6'-O-galloyl)-beta-D-glucopyranosideMeSH

  from Lagerstroemia balansae; structure in first source

• C5855943,4-dimethoxyphenol-beta-D-apiofuranosyl (1-6)-beta-D-glucopyranosideMeSH

  from Nauclea officinalis

• C5875353,4-dimethoxyphenylglucosinolateMeSH

  structure in first source

• C5820973,4-dimethoxystilbeneMeSH

  structure in first source

• C5877653,4-dimethylciprofloxacinMeSH

  structure in first source

• C5694483,4-dimethylthieno(2,3-b)thiopheneMeSH

  structure in first source

• C5708253,4-diphenylbuta-1,3-dienyl isocyanateMeSH

  structure in first source

• C5862833,4-diphenylfuran-2-oneMeSH

  structure in first source

• C5872243,4-seco-12R,13S-dihydroxy-4(18),8(17),14(15)-labdatrien-3-oic acidMeSH

  isolated from the leaves of Callicarpa nudiflora; exerted inhibitory activity against the production of nitric oxide in RAW264.7 stimulated by lipopolysaccharide; structure in first source

• C5737273,4-seco-lup-20(29)-en-3-oic acidMeSH

  antibacterial from Decatropis bicolor; structure in first source

• C5757793,4-secoisopimar-4(18),7,15-trien-3-oic acid, sodium saltMeSH

  anticlastogenic from Salvia cinnabarina; structure in first source

• C5725123,4-tris(difluoromethyl)pyrazoleMeSH

  structure in first source

• C5691583,4:3',4'-bis(O,O-methylene)ellagic acidMeSH

  isolated from leaves and twigs of Pachycentria formosana; structure in first source

• C5751503,5'-dimethoxy-4',7-epoxy-8,3'-neolignane-5,9,9'-triolMeSH

  inhibits nitric oxide production; isolated from Leontopodium leontopodioides; structure in first source

• C5794463,5,10,14,15-pentaacetyl-8-isobutanoyl-cyclomyrsinolMeSH

  from Euphorbia aellenii; structure in first source

• C5796743,5,3',4'-tetrahydroxy-trans-stilbene-4'-O-beta-D-glucopyranosideMeSH

  from Phytolacca americana.;structure in first source

• C5597203,5,4'-trihydroxystilbene-3,5-O-diglucopyranosideMeSH

  an antibacterial isolated from Ficus polita; structure in first source

• C5769013,5,7,3',4'-pentamethoxyflavoneMeSH

  causes relaxation of cavernosum; structure in first source

• C5871103,5,7-triphenyl-1,2-diazacyclohepta-1(7),2-dieneMeSH

  structure in first source